Efficacy and Safety of Dulaglutide Versus Insulin Glargine in Chinese T2DM Patients: A Subgroup Analysis of a Randomized Trial (AWARD-CHN2) | SpringerLink
Efficacy and safety of dulaglutide versus placebo and exenatide in type 2 diabetes (AWARD-1) - Virtual Meeting | EASD
Efficacy and safety profile of once-weekly dulaglutide in type 2 diabe | DMSO
REWIND - Research Studies - PHRI - Population Health Research Institute of Canada
Clinical Trials: A1C, Weight Change & Cardiovascular Data | HCP | Trulicity (dulaglutide)
Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis | Cardiovascular Diabetology | Full Text
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial - The Lancet
Preference for Oral and Injectable GLP-1 RA Therapy Profiles in Japanese Patients with Type 2 Diabetes: A Discrete Choice Experiment | SpringerLink
Effects of Dulaglutide and Insulin Glargine on Estimated Glomerular Filtration Rate in a Real-world Setting - Clinical Therapeutics
Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program - Jendle -
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial - The Lancet
Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study - The Lancet
Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program - Jendle -
REWIND: Dulaglutide reduces stroke risk in type 2 diabetes
Improvement in HbA1c in patients with type 2 diabetes mellitus treated with once weekly dulaglutide across baseline body mass index (BMI) subgroups at 26 or 52 weeks - Virtual Meeting | EASD
Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies - Metabolism - Clinical and Experimental
Summary of clinical trials evaluating the use of GLP-1 agonists to... | Download Scientific Diagram
Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials | SpringerLink
Clinical Outcomes by Albuminuria Status with Dulaglutide versus Insulin Glargine in Participants with Diabetes and CKD: AWARD-7 Exploratory Analysis | American Society of Nephrology
Dulaglutide clinical trial program for data analysis | Download Scientific Diagram
Dulaglutide Shows Sustained Reduction in Glycosylated Hemoglobin Values: 2-Year US Real-world Study Results - Clinical Therapeutics
Trulicity® (dulaglutide) demonstrates superiority
Key drivers of clinical differences between once-weekly semaglutide and... | Download Table
Glycaemic control | OZEMPIC® ▽(semaglutide)
Key characteristics of completed trials and REWIND | Download Table
